Making brain biopsies safer for lymphoma patients
Part of Blood & lymphatic, Brain & nervous system, Cancer, Immune system & allergy clinical trials.
This trial tests a new method to improve the safety and accuracy of brain biopsies in people with a type of lymphoma that starts in the brain or spinal cord. It may help reduce complications and get more reliable results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 years or older)
- You are scheduled for a brain biopsy for a newly diagnosed central nervous system lymphoma
- You do not have severe liver, kidney, or heart problems
- You have not had a heart attack or stroke in the last 3 months
- You are not allergic to contrast agents (dyes used in imaging tests)
- You are not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses brain biopsy and spinal fluid (lumbar puncture) tests to better diagnose and understand how well treatments may work for certain lymphomas in the brain. It may help doctors match the right therapy by studying what the disease looks like in the body and brain.
This trial tests a new type of imaging scan to see if it can better detect and monitor brain lymphoma. It may help doctors tailor treatment by seeing how the cancer responds early on.
This study looks at how primary central nervous system (CNS) lymphoma can be identified and tracked using scans and molecular (tissue/biomarker) tests. It may help doctors better understand your disease and choose the best next steps.
This study checks whether advanced brain MRI images can help doctors choose the best spot to biopsy suspected or proven primary brain tumors. It may help make biopsies safer and more accurate before tissue diagnosis.
This trial studies how newly diagnosed primary central nervous system (brain) non-Hodgkin lymphoma responds to a specific type of radiation to the whole brain, and it also looks at changes in thinking, mood, and behavior. It may help doctors understand how this treatment affects day-to-day brain function.
This study looks at how whole-brain radiation affects thinking, memory, and other brain function in people with blood cancers that involve the brain. It may help doctors understand what to expect and which supportive treatments or monitoring could be useful.
Hear when a new Cerebral Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.